Navigation Links
November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History
Date:11/18/2008

ignored.

"In these economically challenged times, states cannot afford to misuse MSA funds," said Toomey. "The crushing financial burden each state must carry to address the very real costs associated with tobacco-related death and disease will only diminish when smoking rates begin to decline. Yet, the bitter reality is that states are not using the money for what it was intended for."

Alabama spends more than 3 billion dollars on tobacco-related health care costs each year, yet devoted millions of its MSA award to building factories for private employers and supporting flood control projects. Some these funds were even used to counter satanic cults in public schools. What the American Lung Association finds even more shocking is that Virginia actually gave $2 million of its settlement award to Star Tobacco Company to be spent on marketing incentives. North Carolina diverted three-quarters of its settlement dollars to support tobacco production.

"These states are not only guilty of taking money from big tobacco companies and giving it right back, but also guilty of contributing to the public health epidemic that causes almost 393,000 deaths in our country each year," said Toomey.

The American Lung Association calls upon states to stop squandering this money and to address the real issues at hand -- the deadly grip big tobacco has on our nation is literally killing us and contributing to our economic woes. Supporting tobacco cessation and prevention programs will save countless lives and will ease the strain on states' budgets by reducing tobacco-related health care expenditures.

For more information on how states in far too many instances are neglecting to sufficiently protect their residents from the predatory practices of the tobacco industry, visit http://www.stateoftobaccocontrol.org. Her
'/>"/>

SOURCE American Lung Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
2. Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8, 2007
3. Select Medical Corporation to Announce Third Quarter Results on Monday, November 12
4. Cardinal Health To Announce First-Quarter Results on November 5
5. Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park
6. US-Based Bollywood On-Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd
7. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
8. Health Fitness Corp. to Report Third Quarter 2007 Financial Results on November 5, 2007
9. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
10. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
11. Cynosure to Announce Third-Quarter 2007 Financial Results on November 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Research Hospital have demonstrated a more effect...fluenza. They found that the antibiotics clindamyc...ting their protein synthesis, are more effective t...-lactam" antibiotic ampicillin, which causes the b...portant because pneumonia, rather than the influen...
(Date:1/8/2009)...2009 Continues Growth Trend , , NORTH HOLLYWOOD... Hospitalist Company, Inc. (Nasdaq: IPCM ), a le...e company, announced today that it has acquired th...ltants, Inc. (MACC) in St. Louis, Missouri. The ac.... Louis market, where IPC has established a signif...
(Date:1/8/2009)...ire-USNewswire/ -- A new educational Web site offe...gs, biological products and medical devices from t...nters for Education and Research on Therapeutics (... a dozen leading research centers nationwide. The...twork ( CHAIN ) http://www.chainonline.org links...
(Date:1/8/2009)...ness continues to drive overall performance , ,...oration (ZixCorp(R)), (Nasdaq: ZIXI ), the leade...escribing, today offered a corporate update by its...nded the year on a high note in our Email Encrypti...he year in the fourth quarter," said Spurr. "Our ...
Breaking Medicine News(10 mins):Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4
...shed yesterday looks into support props for care g... elucidates the plight of most relatives // and ca...ften the rehabilitation and restoration of confide... realms of hospital in –patient care. It is the v...
...sions for breast cancer fell by a third between 19...ncy for Healthcare Research and Quality. The decli...cilities for breast cancer surgeries, plus the gro...ns such as lumpectomies, which are typically perfo...
...survivors will be able to do away with invasive br...ch involving stem cells //extracted from their own... who are investigating the potential these cells m.... In animal models, the researchers hope to prove...
...hyam Sarda, a prime accused in the expired blood t...nior police official.// "We have arrested Ghanshy...uced in court," said Gyanwant Singh, deputy commis... department). Ghanshyam's brother, Govind Sarda,...
Other Medicine News:Health News:Breast reconstruction may be possible with fat stem cells 2
(Date:1/8/2009)..., CHICAGO, Jan. 8 If you are t... today, you,re not alone. Half of the people takin...ed. The reasons are,varied -- they forget, are bu...ision not to. Noncompliance has been called the Ac...on General Everett Koop commented, "Drugs don,t,w...
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/ -...hat predict a high likelihood of relapse in childr...gh the researchers caution that further research i...led IKZF1 or IKAROS, lead to leukemia relapse,...future diagnostic tests to assess the risk of trea...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua Ho...ua.com ), the worldwide leader in using stem cells...unced today six new globally experienced additions...tly expand the hospital,s treatment capabilities f...nts. The six senior doctors include the distinguis...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In recent ...r, University of Memphis , scientists found that ...n(R), is the first and only proven ingredient to i...hereby increasing blood nitrate/nitrate (NOx) in h...ilator and enables an increase in blood flow to th...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cats Can Trigger Eczema in Some Infants 22745 1Cats Can Trigger Eczema in Some Infants 22745 2Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 1Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 2Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 3Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 22739 1Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 22739 2INSPIRIS Acquires Care Level Management 22736 1INSPIRIS Acquires Care Level Management 22736 2
...e Response or Reduction of,Lesion Size by More tha...PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals ...sitive results from a clinical trial examining the...vestigational therapeutic,vaccine for human papill... highest grade of cervical dysplasia (CIN III). Th...
...07 - Accentia,Biopharmaceuticals, Inc. (NASDAQ: AB... of the American Academy of Allergy, Asthma, and,I..., CA. The,posters discussed findings from a survey... the U.S., U.K., France, and Germany on the,burden...tudes of,the fungal etiology of CS, and the differ...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics.
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110.
Medicine Products: